Studies examining the role of HGFL-RON signaling in regulating these BCSC-specific activities and the identification of novel pathways required for these regulations will further define the mechanisms by which HGFL-RON signaling promotes breast cancer progression and support targeting this signaling pathway in late-stage breast cancers. Here, MST1R is linked to breast carcinoma.